Comparison of Rat and Human Pulmonary Metabolism Using Precision-cut Lung Slices (PCLS)

Area of Science:

• Pharmacology
• Pulmonary Medicine
• Drug Metabolism

Background:

• The liver is the primary site of drug metabolism, but the lungs also possess drug-metabolizing enzymes.
• Pulmonary drug metabolism can contribute to the overall elimination of xenobiotics.
• Investigating lung drug metabolism requires standardized and reliable techniques.

Purpose of the Study:

• To standardize the Precision-cut Lung Slice (PCLS) technique for pulmonary drug metabolism studies.
• To characterize and compare drug-metabolizing enzyme activity in rat and human lung tissue.
• To assess the contribution of pulmonary metabolism to drug elimination.

Main Methods:

• Standardization of the PCLS technique using rat lung tissue.
• Evaluation of pulmonary enzymatic activity in relation to rat age and strain.
• Comparison of tissue incubation systems (Dynamic Organ Culture vs. well-plates) and oxygen supply.
• Assessment of phase I (e.g., Cytochrome P450 - CYP) and phase II probe substrate metabolism in rat and human lung preparations.

Main Results:

• Pulmonary enzymatic activity varied significantly with rat age and strain.
• The Dynamic Organ Culture system was superior for tissue incubations compared to well-plates.
• Cytochrome P450 (CYP) activity was generally low in both rat and human lung preparations.
• Phase II drug-metabolizing enzyme activity was more significant in lung tissue.

Conclusions:

• Precision-cut Lung Slices (PCLS) represent a valuable tool for studying pulmonary drug metabolism.
• Pulmonary CYP activity is relatively low, suggesting a limited role in the metabolism of many drugs.
• Significant differences in enzyme activity exist between rat and human lung tissue, highlighting species-specific considerations in drug development.